However, these effects were significantly decreased in the MSC and PBS groups, indicating that the modulatory activity of the ANS that was eliminated or diminished during the chronic phase after infarction was significantly recovered after HGF-MSC, but not MSC, injection. The gene discussed is HGF; the disease is infarction.